These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27150142)

  • 21. Comparison of fixed versus traditional weight-based dosing of rasburicase in a pediatric population.
    Savva DA; Herrera N; Rohatgi R
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27236. PubMed ID: 29905398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
    Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
    J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rasburicase for the treatment and prevention of hyperuricemia.
    Yim BT; Sims-McCallum RP; Chong PH
    Ann Pharmacother; 2003; 37(7-8):1047-54. PubMed ID: 12841818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea.
    Shin HY; Kang HJ; Park ES; Choi HS; Ahn HS; Kim SY; Chung NG; Kim HK; Kim SY; Kook H; Hwang TJ; Lee KC; Lee SM; Lee KS; Yoo KH; Koo HH; Lee MJ; Seo JJ; Moon HN; Ghim T; Lyu CJ; Lee WS; Choi YM
    Pediatr Blood Cancer; 2006 Apr; 46(4):439-45. PubMed ID: 16123985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults.
    McDonnell AM; Lenz KL; Frei-Lahr DA; Hayslip J; Hall PD
    Pharmacotherapy; 2006 Jun; 26(6):806-12. PubMed ID: 16716134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rasburicase in the treatment of hyperuricemia of newborns.
    Ghirardello S; Ardissino G; Mastrangelo A; Mosca F
    Pediatr Nephrol; 2010 Sep; 25(9):1775; author reply 1777. PubMed ID: 20376501
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rasburicase (Fasturtec)].
    Vogt B; Gugger M; Frey FJ
    Ther Umsch; 2004 Sep; 61(9):579-82. PubMed ID: 15493120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
    Vadhan-Raj S; Fayad LE; Fanale MA; Pro B; Rodriguez A; Hagemeister FB; Bueso-Ramos CE; Zhou X; McLaughlin PW; Fowler N; Shah J; Orlowski RZ; Samaniego F; Wang M; Cortes JE; Younes A; Kwak LW; Sarlis NJ; Romaguera JE
    Ann Oncol; 2012 Jun; 23(6):1640-5. PubMed ID: 22015451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rasburicase improves hyperuricemia in infants with acute kidney injury.
    Hobbs DJ; Steinke JM; Chung JY; Barletta GM; Bunchman TE
    Pediatr Nephrol; 2010 Feb; 25(2):305-9. PubMed ID: 19936796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic analysis of intravenous recombinant urate oxidase using an indirect pharmacological response model in healthy subjects.
    Cai NF; Cheng ZN; Zi Y; Luo X; Guo X; Liu Z; Zheng LY
    Acta Pharmacol Sin; 2014 Nov; 35(11):1447-52. PubMed ID: 25283504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More to rasburicase than uric Acid.
    Patel S; Le AN
    Pharmacotherapy; 2013 Sep; 33(9):e177. PubMed ID: 23744455
    [No Abstract]   [Full Text] [Related]  

  • 32. Rasburicase improves hyperuricemia in patients with acute kidney injury secondary to rhabdomyolysis caused by ecstasy intoxication and exertional heat stroke.
    Lin PY; Lin CC; Liu HC; Lee MD; Lee HC; Ho CS; Chiu NC; Peng CC; Huang FY; Tsai JD
    Pediatr Crit Care Med; 2011 Nov; 12(6):e424-7. PubMed ID: 21572370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rasburicase and tumor lysis syndrome: lower dosage, consideration of indications, and hyperhydration.
    Darmon M; Guichard I; Vincent F
    J Clin Oncol; 2011 Jan; 29(3):e67-8; author reply e69. PubMed ID: 21149649
    [No Abstract]   [Full Text] [Related]  

  • 34. Rational use of rasburicase for the treatment and management of tumor lysis syndrome.
    Shaikh SA; Marini BL; Hough SM; Perissinotti AJ
    J Oncol Pharm Pract; 2018 Apr; 24(3):176-184. PubMed ID: 28077046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of rasburicase in hyperuricemia secondary to Lesch-Nyhan syndrome.
    Roche A; Pérez-Dueñas B; Camacho JA; Torres RJ; Puig JG; García-Cazorla A; Artuch R
    Am J Kidney Dis; 2009 Apr; 53(4):677-80. PubMed ID: 18992978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy.
    Pession A; Barbieri E; Santoro N; Paolucci P; Porta F; Locatelli F
    Haematologica; 2005 Jan; 90(1):141-2. PubMed ID: 15642687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia.
    Trifilio S; Gordon L; Singhal S; Tallman M; Evens A; Rashid K; Fishman M; Masino K; Pi J; Mehta J
    Bone Marrow Transplant; 2006 Jun; 37(11):997-1001. PubMed ID: 16708061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies.
    Trifilio SM; Pi J; Zook J; Golf M; Coyle K; Greenberg D; Newman D; Koslosky M; Mehta J
    Bone Marrow Transplant; 2011 Jun; 46(6):800-5. PubMed ID: 20818444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
    Bosly A; Sonet A; Pinkerton CR; McCowage G; Bron D; Sanz MA; Van den Berg H
    Cancer; 2003 Sep; 98(5):1048-54. PubMed ID: 12942574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rasburicase therapy may cause hydrogen peroxide shock].
    Góth L
    Orv Hetil; 2008 Aug; 149(34):1587-90. PubMed ID: 18708312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.